The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: A review

被引：46
|
作者：
Crunelle, Cleo L. [1 ,2 ,3 ]
Miller, Michelle L. [1 ,2 ,3 ]
Booij, Jan [3 ]
van den Brink, Wim [1 ,2 ]
机构：
[1] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1070 AW Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Addict Res, NL-1070 AW Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Nucl Med, NL-1070 AW Amsterdam, Netherlands
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2010年 / 20卷 / 02期
关键词：
Varenicline; Atpha4 beta2 nicotinic acetylcholine receptor; Partial agonist; Addiction; Drug dependence; Relapse prevention; VENTRAL TEGMENTAL AREA; ACCUMBAL DOPAMINE OVERFLOW; VOLUNTARY ETHANOL INTAKE; SMOKING-CESSATION; MOLECULAR-MECHANISMS; MESOLIMBIC DOPAMINE; REINFORCING PROPERTIES; SYNAPTIC-TRANSMISSION; INDUCED HYPERACTIVITY; NUCLEUS-ACCUMBENS;
D O I：
10.1016/j.euroneuro.2009.11.001
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Drug dependence is a chronic brain disease characterized by recurrent episodes of relapse, even when the person is motivated to quit. Relapse is a major problem and new pharmacotherapies are needed to prevent relapse episodes. The nicotinic acetylcholine receptor (nAChR) plays an important rote in nicotine dependence, alcohol consumption and cue-induced cocaine craving. Stimulation of the nAChR has been found to alter and modulate cell firing in brain areas important for the maintenance of drug dependence. Varenicline, an alpha 4 beta 2 nAChR partial agonist and an alpha 7 nAChR full agonist registered for the treatment of nicotine dependence, significantly reduces nicotine craving and prevents relapse. In addition, varenicline reduces alcohol consumption in rats. Based on a review of the available literature, we hypothesize a potential rote for varenicline in the prevention of relapse in patients recovering from drug dependence other than nicotine dependence. (C) 2009 Elsevier B.V. and ECNP. All rights reserved.
引用
收藏
页码：69 / 79
页数：11
相关论文
共 50 条
  • [1] Varenicline - a nicotinic receptor partial agonist for treatment of alcohol dependence
    Obsada, Natalia
    Zalewska-Kaszubska, Jadwiga
    ALKOHOLIZM I NARKOMANIA-ALCOHOLISM AND DRUG ADDICTION, 2016, 29 (02): : 93 - 101
  • [2] Varenicline, an α402 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking
    Steensland, Pia
    Simms, Jeffrey A.
    Holgate, Joan
    Richards, Jemma K.
    Bartlett, Selena E.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (30) : 12518 - 12523
  • [3] Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation
    Oncken, Cheryl
    Gonzales, David
    Nides, Mitchell
    Rennard, Stephen
    Watsky, Eric
    Billing, Clare B.
    Anziano, Richard
    Reeves, Karen
    ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (15) : 1571 - 1577
  • [4] DECAMETHONIUM IS A PARTIAL AGONIST AT THE NICOTINIC ACETYLCHOLINE-RECEPTOR
    LIU, Y
    DILGER, JP
    SYNAPSE, 1993, 13 (01) : 57 - 62
  • [5] Case History: Chantix™/Champix™ (Varenicline Tartrate), a Nicotinic Acetylcholine Receptor Partial Agonist as a Smoking Cessation Aid
    Coe, Jotham W.
    Rollema, Hans
    O'Neill, Brian T.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 44, 2009, 44 : 71 - +
  • [6] Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid
    Rollema, H.
    Chambers, L. K.
    Coe, J. W.
    Glowa, J.
    Hurst, R. S.
    Lebel, L. A.
    Lu, Y.
    Mansbach, R. S.
    Mather, R. J.
    Rovetti, C. C.
    Sands, S. B.
    Schaeffer, E.
    Schulz, D. W.
    Tingley, F. D., III
    Williams, K. E.
    NEUROPHARMACOLOGY, 2007, 52 (03) : 985 - 994
  • [7] Varenicline:: An α4β2 nicotinic receptor partial agonist for smoking cessation
    Coe, JW
    Brooks, PR
    Vetelino, MG
    Wirtz, MC
    Arnold, EP
    Huang, JH
    Sands, SB
    Davis, TI
    Lebel, LA
    Fox, CB
    Shrikhande, A
    Heym, JH
    Schaeffer, E
    Rollema, H
    Lu, Y
    Mansbach, RS
    Chambers, LK
    Rovetti, CC
    Schulz, DW
    Tingley, FD
    O'Neill, BT
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (10) : 3474 - 3477
  • [8] Efficacy and safety of varenicline, an α4β2 acetylcholine nicotinic receptor partial agonist, for smoking cessation in Japanese smokers
    Nakamura, Masakazu
    Fujimoto, Yoko
    Maruyama, Nami
    Ishibashi, Taro
    Reeves, Karen
    CIRCULATION, 2006, 114 (18) : 856 - 856
  • [9] The efficacy and tolerability of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, for smoking cessation in Taiwanese and Korean smokers
    Kim, Dac-Hyun
    Tsai, Shih-Tzu
    Cho, Hong-Jun
    Chang, Wen-Dau
    Kim, Cheol-Hwan
    Cheng, Huey-Shinn
    Cho, BeLong
    Guo, Fei-Rarl
    Paek, Yu-Jin
    Hsueh, Kuang-Chieh
    Billing, Clare B., Jr.
    Williams, Kathryn E.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 122 : 82 - 82
  • [10] EFFICACY OF VARENICLINE, AN NICOTINIC ACETYLCHOLINE RECEPTOR PARTIAL AGONIST, VS PLACEBO FOR SMOKING CESSATION. A RANDOMIZED CONTROLLED TRIAL
    Wiratmoko, Mirsyam R.
    Yunus, Faisal
    Susanto, Agus D.
    Ginting, Tribowo T.
    Kekalih, Aria
    RESPIROLOGY, 2013, 18 : 66 - 66
12345